Why CGM Readings Differ from Fingerstick Blood Glucose
CGMs measure glucose in interstitial fluid rather than blood, creating an inherent physiological lag and measurement difference compared to fingerstick capillary blood glucose testing. 1
Fundamental Physiological Difference
The primary reason for discordance is the different biological compartments being measured:
- CGMs measure interstitial glucose in the subcutaneous tissue, while fingerstick meters measure capillary blood glucose directly 1
- Glucose must diffuse from capillaries into interstitial fluid, creating a physiological time lag of approximately 5-15 minutes 1
- This lag becomes most pronounced during rapid glucose changes, particularly during insulin-induced glucose decline or after carbohydrate ingestion 2
Accuracy Limitations and Magnitude of Discordance
Recent high-quality research quantifies these differences:
- CGMs consistently underestimate postprandial glucose rises by an average of 12.8 mg/dL compared to gold-standard laboratory measurements 3
- The mean absolute relative difference (MARD) for CGMs is approximately 13.7% versus 8.0% for fingerstick meters when compared to laboratory standards 3
- Different CGM systems show variable accuracy: Dexcom G6 tends to read higher than blood glucose, while Freestyle Libre tends to read lower 4
Clinical Situations Where Discordance Is Greatest
Dynamic glucose changes amplify the discrepancy between CGM and fingerstick readings:
- During rapid glucose decline (such as after insulin administration), CGMs lag behind actual blood glucose values 2
- During rapid glucose rise (such as after meals), the time lag causes CGMs to underestimate peak glucose values 3
- In stable glucose conditions, the discordance is minimal 2
Time-Dependent Sensor Performance
CGM accuracy varies with sensor age:
- Sensor sensitivity changes logarithmically with both time after insertion and glucose levels 5
- The first 12-24 hours after sensor insertion show the greatest inaccuracy, as sensors have not fully equilibrated 5
- Standard manufacturer calibration algorithms may not account adequately for this early time period 5
Important Clinical Caveats
Do not use CGM readings alone for acute treatment decisions during rapid glucose changes:
- CGMs may overestimate time spent in hypoglycemia (<70 mg/dL) and underestimate time in target range (70-180 mg/dL) compared to actual blood glucose 3
- During suspected hypoglycemia or rapid glucose changes, confirm with fingerstick testing before making insulin dosing decisions 1
- CGM accuracy limitations are particularly important in hospitalized patients where rapid glucose fluctuations are common 6
Complementary Rather Than Replacement Technology
The ADA/EASD joint statement emphasizes that:
- CGMs provide trend data and patterns that fingerstick testing cannot capture, showing direction and rate of glucose change 1
- CGMs excel at identifying overall glycemic patterns, variability, and time in range over days to weeks 1
- Fingerstick testing remains more accurate for point-in-time decision-making, particularly during dynamic glucose changes 3